Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jul;139(6):1219-27.
doi: 10.1038/sj.bjp.0705350.

Adrenomedullin upregulates M2-muscarinic receptors in cardiomyocytes from P19 cell line

Affiliations

Adrenomedullin upregulates M2-muscarinic receptors in cardiomyocytes from P19 cell line

Sophie Buys et al. Br J Pharmacol. 2003 Jul.

Abstract

1. The effects of AM on expression of muscarinic (M) receptors from P19-derived cardiomyocytes were examined. 2. RT-PCR experiments revealed expression of M(1)-M(4) receptor genes. Immuno-histochemistry indicated that M(2) expression is restricted to contractile cells. Carbachol inhibition of isoprenaline-induced increase in beating rate was prevented by atropine and methoctramine (pA(2): 8.1). Inhibition of [(3)H]-NMS binding by atropine (pK(i): -8.4+/-0.2) and methoctramine (pK(i): -8.3+/-0.2) suggests that M(2) is the functional expressed isoform. 3. [(3)H]-NMS binding and semiquantitative RT-PCR studies showed a dome shaped time course of M(2) expression with a maximum at 7 days of differentiation followed by a progressive decline. 4. AM concentration-dependently upregulated M(2) receptor mRNA during late differentiation stages in P19 cells but also in rat atrial cardiomyocytes. This effect was potentiated by factor H. AM (100 nM) plus factor H (50 nM) treatment of P19 cells for 24 h significantly increased [(3)H]-NMS-specific binding (B(max): 81+/-7 vs 31+/-6 fmol mg(-1) prot). The effect of AM on mRNA levels was prevented by AM receptor antagonist AM(22-52) (1 micro M) but not by CGRP antagonist, CGRP(8-37) (1 micro M). 5. The mRNA levels encoding CRLR receptor declined with culture duration, whereas those encoding L1/G10D receptor remained stable. 6. Our findings demonstrate that AM regulates M(2) receptors expression in cardiomyocytes probably through a mechanism involving L1/G10D receptors. The 'in vivo' significance of this phenomenon remains to be demonstrated.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Characterization of muscarinic receptors on P19-derived cardiomyocytes. (A) RT–PCR analysis of mRNA expression for muscarinic receptors M1–M4 in P19 differentiated cardiomyocytes. D9 and D15 indicate 9 and 15 days of differentiation respectively. (−) is a control PCR without reverse transcription of the mRNA. Band sizes are indicated. (B) Inhibition of the isoprenaline-induced increase in beating rate by increasing concentrations of carbachol alone (n=8, open squares) or in the presence of a fixed concentration (10 μM) of atropine (n=8, filled squares), methoctramine (n=12, filled circles) or pirenzepine (n=8, open circles). (C) Inhibition of [3H]-NMS binding by atropine (n=6, filled line), methoctramine (n=6, hatched line) and pirenzepine (n=6, dotted line). (D) Top: Colocalization of M2 muscarinic receptor and desmin by immunofluorescent staining of P19 differentiated cardiomyocytes (representative example of four experiments). M2 is revealed by a rhodamine-coupled antibody (a) and desmin is revealed by a FITC-coupled antibody (b). Bottom: negative controls: c and d.
Figure 2
Figure 2
Time course expression of M2 muscarinic receptor mRNA in P19 cells during differentiation. Semiquantitative RT–PCR were performed from day 1 (D1) to day 15 (D15). 18S mRNA are used as internal standard. Values of M2/18S ratio are depicted on bottom line of the figure.
Figure 3
Figure 3
Effects of AM with or without factor H on M2 muscarinic receptor mRNA expression in P19 cardiomyocytes and rat atrial cardiomyocytes. Mean±s.e.m. of six separate experiments using real-time quantitative PCR with 18S mRNA used as standard for normalization. *P<0.05 vs control values. (a) Effect of increasing AM concentrations on 15 days differentiated P19 cardiomyocytes. Statistical analysis was performed using ANOVA. (b) Effect of two concentrations of factor H added to a fixed concentration of AM. (c) Effect of AM alone or associated with factor H on isolated rat atrial cardiomyocytes.
Figure 4
Figure 4
RT–PCR analysis of mRNA expression from L1/G10D and CRLR receptors and RAMP1–3 proteins. Sizes of the bands are indicated between parentheses.
Figure 5
Figure 5
Effect of antagonists of L1/G10D (AM22–52) and CRLR (CGRP8-37) receptors on the induction of M2 mRNA expression by AM plus factor H. Experiments were monitored by real-time PCR in P19 cardiomyocytes (D15 of differentiation) using 18S RNA as standard for normalization. Mean±s.e.m. of three independent experiments.*P<0.05.
Figure 6
Figure 6
Temporal evolution of L1/G10D and CRLR receptors and of GATA4 mRNAs in P19 cells during culture from day 1 (D1) to day 15 (D15). Results of semiquantitative RT–PCR analysis using 18S mRNA as internal standard. For L1/G10D and CRLR the value of ratio of expression over 18S expression is provided at each time.

References

    1. AUTELITANO D.J. Cardiac expression of genes encoding putative adrenomedullin/calcitonin gene-related peptide receptors. Biochem. Biophys. Res .Commun. 1998;250:689–693. - PubMed
    1. AUTELITANO D.J., RIDINGS R. Adrenomedullin signalling in cardiomyocytes is dependent upon CRLR and RAMP2 expression. Peptides. 2001;22:1851–1857. - PubMed
    1. AUTELITANO D.J., RIDINGS R., TANG F. Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro. Cardiovasc. Res. 2001;51:255–264. - PubMed
    1. BRODDE O.E., KONSCHAK U., BECKER K., RUTER F., POLLER U., JAKUBETZ J., RADKE J., ZEKOWSKI H.R. Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies. J. Clin. Invest. 1998;101:471–478. - PMC - PubMed
    1. CAUFIELD M.P. Muscarinic receptor: characterization, coupling and function. Pharmacol. Ther. 1993;58:319–379. - PubMed